Intracellular delivery of VIP-grafted sterically stabilized phospholipid mixed nanomicelles in human breast cancer cells

Chemico-Biological Interactions

Volumn 171, Issue 2, 2008, Pages 190-194

  Rubinstein, Israel ^a,c   Soos, Imre ^b   Onyuksel, Hayat ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois at Chicago   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Drug delivery; DSPE PEG2000; Galanin; Nanobiotechnology; Nanomedicine; PACAP; Phosphatidylcholine; Quantum dots

Indexed keywords

CADMIUM SELENIDE; GALANIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; PHOSPHOLIPID DERIVATIVE; QUANTUM DOT; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; ZINC SULFIDE;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MICELLE; NANOTECHNOLOGY; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; CELL LINE, TUMOR; HUMANS; MICELLES; MICROSCOPY, CONFOCAL; PHOSPHOLIPIDS; QUANTUM DOTS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 38349191067     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.03.008     Document Type: Article

References (26)

1. Koo O., Rubinstein I., and Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 1 (2005) 193-212
2. Gespach C., Bawab W., de Cremoux P., and Calvo F. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Cancer Res. 48 (1988) 5079-5083
3. Dagar S., Krishnadas A., Rubinstein I., Blend M.J., and Onyuksel H. VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies. J. Control Release 91 (2003) 123-133
4. Allen C., Dos Santos N., Gallagher R., Chiu G.N.C., Shu Y., Li W.M., Johnstone S.A., Janoff A.S., Mayer L.D., Webb M.S., and Bally M.B. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci. Rep. 22 (2002) 225-250
5. Gao X., Cui Y., Levenson R.M., Chung L.W.K., and Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22 (2004) 969-976
6. Krishnadas A., Rubinstein I., and Onyuksel H. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm. Res. 20 (2003) 297-302
7. Ashok B., Arleth L., Hjelm R.P., Rubinstein I., and Onyuksel H. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J. Pharm. Sci. 93 (2004) 2476-2487
8. Arleth L., Ashok B., Onyuksel H., Thiyagarajan P., Jacob J., and Hjelm R.P. Detailed structure of hairy mixed micelles formed by phosphatidylcholine and PEGylated phospholipids in aqueous media. Langmuir 21 (2005) 3279-3290
9. Ashok B., Rubinstein I., Tsueshita T., and Onyuksel H. Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP1-38 in PEGylated phospholipid micelles. Peptides 25 (2004) 1253-1258
10. Krishnadas A., Rubinstein I., Sekosan M., and Onyuksel H. Targeted delivery of paclitaxel to breast cancer by vasoactive intestinal peptide conjugated sterically stabilized phospholipid mixed micelles. AAPS J. 6 Suppl. 1 (2004) M1191
11. Alivisatos P., Gu W., and Larabell C. Quantum dots as cellular probes. Annu. Rev. Biomed. Eng. 7 (2005) 55-76
12. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Sundaresan G., Wu A.M., Gambhir S.S., and Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307 (2005) 538-544
13. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., and Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298 (2002) 1759-1762
14. Dagar S., Sekosan S.M., Lee B.S., Rubinstein I., and Onyuksel H. VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery. J. Control Release 74 (2001) 129-134
15. Krishnadas A., Rubinstein I., and Onyuksel H. Vasoactive Intestinal Peptide (VIP) conjugated phospholipid nanocarrier for active targeted delivery of paclitaxel to breast cancer. Controlled Release Society 31st Annual Meeting Transactions #497 (2004)
16. Bentzen E.L., Tomlinson I.D., Mason J., Gresch P., Warnement M.R., Wright D., Sanders-Bush E., Blakely R., and Rosenthal S.J. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjug. Chem. 16 (2005) 1488-1494
17. Tomlinson I.D., Mason J.N., Blakely R.D., and Rosenthal S.J. Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells. Methods Mol. Biol. 303 (2005) 51-60
18. Fan H., Leve E.W., Scullin C., Gabaldon J., Tallant D., Bunge S., Boyle T., Wilson M.C., and Brinker C.J. Surfactant-assisted synthesis of water-soluble and biocompatible semiconductor quantum dot micelles. Nano Lett. 5 (2005) 645-648
19. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin and caveolae mediated endocytosis. Biochem. J. 377 (2004) 159-169
20. Mousavi S., Malerod L., Berg T., and Kjeken R. Clathrin-dependent endocytosis. Biochem. J. 377 (2004) 1-16
21. Hubbell J. Enhancing drug function. Science 300 (2003) 595-596
22. Savic R., Luo L., Eisenberg A., and Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300 (2003) 615-618
23. Izzo R.S., Scipione R.A., Pellecchia C., and Lokchander R.S. Binding and internalization of VIP in rat intestinal epithelial cells. Regul. Pept. 33 (1991) 21-30
24. McDonald T.P., Dinnis D.M., Morrison C.F., and Harmar A.J. Desensitization of the human vasoactive intestinal peptide receptor (hVIP2/PACAP R): evidence for agonist-induced receptor phosphorylation and internalization. Ann. N.Y. Acad. Sci. 865 (1998) 64-72
25. Nielsen F.C., Gammeltoft S., Westermark B., and Fahrenkrug J. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line. Peptides 11 (1990) 1225-1231
26. Langlet C., Langer I., Vertongen P., Gaspard N., Vanderwinden J.M., and Robberecht P. Contribution of the carboxyl terminus of the VPAC1 receptor to agonist-induced receptor phosphorylation, internalization, and recycling. J. Biol. Chem. 280 (2005) 28034-28043